{"id":"n_es7btpishkc7ka6xw4dq","seq":9639104,"kind":"article","title":"Taking Ozempic or Zepbound? FDA orders warning about rare vision loss risk","url":"https://www.columbian.com/news/2026/nov/10/taking-ozempic-or-zepbound-fda-orders-warning-about-rare-vision-loss-risk","summary":"The Food and Drug Administration is requiring new warnings on GLP-1 drugs, including Ozempic, Wegovy and Zepbound, about a potential increased risk of a rare eye condition that can cause permanent vision loss.","published":"2026-11-10T22:39:43Z","seen":"2026-11-10T23:04:02Z","lang":"en","country":"US","source":{"id":"kite-columbian-com-a45f7c","name":"columbian.com","domain":"columbian.com"},"via":"kite-columbian-com-a45f7c","topics":["washington","health","health wire","latest news","nation & world"],"authors":["Maria Salette Ontiveros, The Dallas Morning News"],"image":"https://www.columbian.com/wp-content/uploads/2026/11/US-NEWS-MED-WEIGHTLOSS-DRUGS-VISION-FILEPIC-GET-768x512.jpg","mentions":2,"story":"st_ip5lwh6i62lc5aqavsnq","category":"health","category_p":0.82,"sentiment":"neutral","tone":-0.43,"political":0.06}